Stan Finkelstein, MD (course co-director) is a Senior Research Scientist in MIT's Institute for Data, Systems and Society in the Schwarzman College of Computing and Associate Professor of Medicine at HMS and founding director of the MD/MBA joint degree program with Harvard Business School. His research focuses on the business-government interface, medical technology, cost-effectiveness and third-party reimbursement.
Peter Sorger, PhD (course co-director) is a Professor in the Dept. of Systems Biology at Harvard Medical School (HMS) and founding Head of the Harvard Program in Therapeutic Science. He was previously on the MIT faculty as professor of Biology and Biological Engineering. Sorger's research focuses on mammalian signal transduction, cancer and its treatment.
Han Xu, PhD(Instructor) is a scientific outreach and education specialist at Harvard Program in Therapeutic Science (HiTS). Han has a background in biomedical engineering. In her current role, Han develops and teaches educational and training programs for HiTS.
Raluca Cobzaru, BA (TA) is a PhD student in the Operations Research program at MIT. Her research is focused on developing robust models for causal inference with applications in drug repurposing.
Anna Thérèse Mehra (TA) is a Senior at Harvard College and a Research Assistant in the Dr. George Church Lab at Harvard Medical School. Her interests include the applications of CRISPR-Cas gene therapy for rare genetic diseases.
Joshua Apgar, PhD, a former MIT graduate student, is Co-Founder and Chief Scientific Officer (CSO) of Applied Biomath, a startup company in Concord MA.
Birgit Schoeberl, PhD, a former MIT postdoc, is Global Head of Modeling and Simulation and PK Sciences at Novartis Institutes for BioMedical Research (NIBR) in Cambridge MA.
Ariel Stern, PhD is an Associate Professor of Business Administration in the Technology and Operations Management Unit at Harvard Business School.
Nicole LeBoeuf, MD, MPH is Clinical Director of the Center for Cutaneous Oncology at the Brigham and Women's Hospital.
George Demetri, MD is a Professor of Medicine at Harvard Medical School and Director of the Center for Sarcoma and Bone Oncology at the Dana-Farber Cancer Institute.
Mike Rosenblatt, MD is Cheif Medical Officer (CMO) of Flagship Pioneering in Cambridge MA; he was previously CMO of Merck, Dean of Tufts University School of Medicine, and a Professor at Harvard Medical School.
Brian Alexander, MD, MPH is Chief Medical Officer of Foundation Medicine in Cambridge MA; he is an Associate Professor of Radiation Oncology at Harvard Medical School and the Dana-Farber Cancer Institute.
John Young, PhD, is the Global Head Infectious Diseases and Vice President at Roche.
Dan H. Barouch, MD, PhDis the William Bosworth Castle Professor of Medicine at Harvard Medical School and the Director of the Center for Virology and Vaccine Research at BIDMC